Come up with a name for your new list and we'll add to it:
AbCellera Biologics raised a round of funding on January 20, 2017. Investors include
Bill & Melinda Gates Foundation.
AbCellera Biologics is a privately held company that provides technologies to biotechnology and pharmaceutical partners with the goal of discovery and development of next-generation monoclonal antibod…